anyone else notice retatrutide kicking in around week 83
Reporting in. anyone else notice retatrutide kicking in around week 83. Nothing containing this compound is approved anywhere. Research-use-only material is not approved for human use, and that is a statement of fact rather than a disclaimer. The phase 2 readout ran to 48 weeks in a few hundred participants with a…
wait for phase 3 before you argue about rankings
the glucagon component is why the metabolic story reads differently
Has anyone posted an independent test on this compound recently?
What is the source for that figure — the published paper or a summary of it?
the escalation is where most of the reported trouble sits
Small fix — three receptors, not two. GLP-1, GIP and glucagon, and the third one is the reason this compound gets its own board.
nothing here is available as a prescription product, so read every thread with that in mind